The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer

Completed

Conditions: Pancreatic Cancer

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2009-05-12

Last Posted Date: 2013-03-05

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 50

Registration Number: NCT00897832

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

Collecting and Storing Tissue Samples From Women With or Without Breast Cancer

Recruiting

Conditions: Breast Cancer

Interventions: Other: biologic sample preservation procedure

First Posted Date: 2009-05-12

Last Posted Date: 2024-08-26

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 4000

Registration Number: NCT00899301

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 74

Registration Number: NCT00898664

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Completed

Conditions: Gestational Trophoblastic Tumor
Ovarian Cancer
Testicular Germ Cell Tumor
Breast Cancer
Leukemia
Myelodysplastic Syndromes
Neuroblastoma
Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Lymphoma

Interventions: Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: polymorphism analysis
Genetic: proteomic profiling
Other: flow cytometry
Other: immunologic technique
Other: laboratory biomarker analysis
Procedure: biopsy

First Posted Date: 2009-05-12

Last Posted Date: 2012-11-06

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 190

Registration Number: NCT00900406

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2012-09-10

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 29

Registration Number: NCT00897052

Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer

Terminated

Conditions: Solid Tumor

First Posted Date: 2009-05-12

Last Posted Date: 2013-01-29

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 10

Registration Number: NCT00898027

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: laboratory biomarker analysis
Other: medical chart review

First Posted Date: 2009-05-12

Last Posted Date: 2018-05-04

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 26

Registration Number: NCT00897468

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Completed

Conditions: Healthy, no Evidence of Disease
Lung Cancer

Interventions: Genetic: proteomic profiling
Other: biologic sample preservation procedure
Other: laboratory biomarker analysis
Procedure: bronchoscopy

First Posted Date: 2009-05-12

Last Posted Date: 2014-06-24

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 37

Registration Number: NCT00899457

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

Terminated

Conditions: Lung Cancer

Interventions: Genetic: protein expression analysis
Genetic: proteomic profiling
Other: biologic sample preservation procedure
Other: laboratory biomarker analysis
Other: matrix-asst laser desorption/ionization time flight mass spectrometry
Other: questionnaire administration

First Posted Date: 2009-05-12

Last Posted Date: 2014-06-24

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 564

Registration Number: NCT00898209

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Terminated

Conditions: Head and Neck Cancer

Interventions: Genetic: DNA and tissue microarray analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: mass spectrometry

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 58

Registration Number: NCT00898742

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy